Akums Drugs

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE09XN01023
  • NSEID: AKUMS
  • BSEID: 544222
INR
696.05
-16.3 (-2.29%)
BSENSE

Nov 20

BSE+NSE Vol: 1.59 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Corona Remedies
Akums Drugs
Aarti Pharma
Marksans Pharma
Blue Jet Health
Sudeep Pharma
Viyash Scientifi
P & G Health Ltd
Concord Biotech
Jubilant Pharmo
Symbiotec Pharma
Why is Akums Drugs & Pharmaceuticals Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0 times
2
Low Debt Company with Strong Long Term Fundamental Strength
3
With a growth in Net Profit of 168.31%, the company declared Very Positive results in Sep 26
  • The company has declared positive results for the last 2 consecutive quarters
  • OPERATING PROFIT TO INTEREST(Q) Highest at 7.58 times
  • ROCE(HY) Highest at 17.48%
  • PBDIT(Q) Highest at Rs 194.73 cr.
4
Stock is technically in a Mildly Bullish range
  • Multiple factors for the stock are Mildly Bullish like Bollinger Band, DOW and OBV
5
With ROE of 10.8, it has a Fair valuation with a 3.1 Price to Book Value
  • Over the past year, while the stock has generated a return of 64.98%, its profits have risen by 23.6% ; the PEG ratio of the company is 1.2
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Akums Drugs should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Akums Drugs for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Akums Drugs
64.98%
1.83
35.45%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
8.77%
EBIT Growth (5y)
54.47%
EBIT to Interest (avg)
4.79
Debt to EBITDA (avg)
1.17
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
1.61
Tax Ratio
29.18%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
15.58%
ROCE (avg)
14.04%
ROE (avg)
10.24%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
29
Industry P/E
40
Price to Book Value
3.12
EV to EBIT
18.57
EV to EBITDA
14.01
EV to Capital Employed
4.82
EV to Sales
1.94
PEG Ratio
1.23
Dividend Yield
0.43%
ROCE (Latest)
25.98%
ROE (Latest)
10.77%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

26What is working for the Company
OPERATING PROFIT TO INTEREST(Q)

Highest at 7.58 times

ROCE(HY)

Highest at 17.48%

PBDIT(Q)

Highest at Rs 194.73 cr.

PBT LESS OI(Q)

Highest at Rs 125.83 cr.

PAT(Q)

Highest at Rs 112.85 cr.

DEBTORS TURNOVER RATIO(HY)

Highest at 5.62 times

NET SALES(Q)

Highest at Rs 1,342.39 cr

EPS(Q)

Highest at Rs 7.37

-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Akums Drugs
Operating Profit to Interest - Quarterly
Highest at 7.58 times and Grown
each quarter in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Operating Profit (PBDIT) - Quarterly
Highest at Rs 194.73 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 125.83 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 125.83 cr has Grown at 60.6% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 78.34 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 112.85 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 112.85 cr has Grown at 47.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 76.33 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 1,342.39 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 7.37
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Debtors Turnover Ratio- Half Yearly
Highest at 5.62 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio